Trial Profile
A Randomized Study of the Effects of Dapagliflozin+Saxagliptin in Addition to Metformin Versus Single Addition Saxagliptin or Dapagliflozin on Glucose Metabolism in Patients With DM2 Poorly Controlled With Metformin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2022
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Nov 2022 Status changed from recruiting to completed.
- 24 May 2022 Planned End Date changed from 1 Feb 2022 to 31 Aug 2022.
- 24 May 2022 Planned primary completion date changed from 31 Jan 2022 to 31 Jul 2022.